The diabetes epidemic: Addressing diagnostic and therapeutic challenges

Therapy

Volumn 8, Issue 2, 2011, Pages 103-104

  McFarlane, Samy I ^a   Bahtiyar, Gul ^b  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; BIOLOGICAL MARKER; EXENDIN 4; GLITAZONE DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INCRETIN; INSULIN; LIRAGLUTIDE; SAXAGLIPTIN; SITAGLIPTIN; SULFONYLUREA;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CHRONIC KIDNEY FAILURE; COST OF ILLNESS; DIABETES MELLITUS; EARLY DIAGNOSIS; EDITORIAL; EPIDEMIC; GLYCEMIC CONTROL; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; RISK REDUCTION; TREATMENT PLANNING; WEIGHT GAIN;

EID: 79953244544     PISSN: 14750708     EISSN: 1744831X     Source Type: Journal    
DOI: 10.2217/thy.11.6     Document Type: Editorial

References (21)

1. Ayach BB, Korda H: Type 2 diabetes epidemic in First Nations people of Canada. Ethn. Dis. 20, 300-303 (2010).
2. Davis GA: The epidemic of diabetes for SC. SC Nurse 17, 1 (2010).
3. Low LC: The epidemic of Type 2 diabetes mellitus in the Asia-Pacific region. Pediatr. Diabetes 11, 212-215 (2010).
4. Moore PA, Zgibor JC, Dasanayake AP: Diabetes: a growing epidemic of all ages. J. Am. Dent. Assoc. 134, 11S-15S (2003).
5. Wiegand S: Type 2 diabetes in children: a new epidemic in Europe? MMW Fortschr. Med. 152, 42-45 (2010).
6. Wilmot EG, Davies MJ, Yates T, Benhalima K, Lawrence IG, Khunti K: Type 2 diabetes in younger adults: the emerging UK epidemic. Postgrad. Med. J. 86, 711-718 (2010).
7. Wylie-Rosett J: The diabetes epidemic: what can we do? J. Am. Diet Assoc. 109, 1160-1162 (2009).
8. Danaei G, Friedman AB, Oza S, Murray CJ, Ezzati M: Diabetes prevalence and diagnosis in US states: analysis of health surveys. Popul. Health Metr. 7, 16 (2009).
9. Collins AJ, Kasiske B, Herzog C et al.: Excerpts from the united states renal data system 2003 annual data report: atlas of end-stage renal disease in the united states. Am. J. Kidney Dis. 42(6 Suppl. 5), A5-A7, S1-S230 (2003).
10. McCullough PA, Li S, Jurkovitz CT et al.: CKD and cardiovascular disease in screened high-risk volunteer and general populations: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am. J. Kidney Dis. 51, S38-S45 (2008).
11. Whaley-Connell AT, Sowers JR, McFarlane SI et al.: Diabetes mellitus in CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition and Examination Survey (NHANES) 1999-2004. Am. J. Kidney Dis. 51, S21-S29 (2008).
12. Saely CH, Drexel V, Vonbank A, Drexel H: Lipid management in Type 2 diabetes: the case for combination therapy? Therapy 8(2), 129-141 (2011).
13. McFarlane SI, Muniyappa R, Francisco R, Sowers JR: Clinical review 145: Pleiotropic effects of statins: lipid reduction and beyond. J. Clin. Endocrinol. Metab. 87, 1451-1458 (2002).
14. Judge EP, Phelan D, O'Shea D: Beyond statin therapy: a review of the management of residual risk in diabetes mellitus. J. R. Soc. Med. 103, 357-362 (2010).
15. McFarlane SI, Banerji M, Sowers JR: Insulin resistance and cardiovascular disease. J. Clin. Endocrinol. Metab. 86, 713-718 (2001).
16. Tremble JM, Donaldson D: Is continued weight gain inevitable in Type 2 diabetes mellitus? J. R. Soc. Promot. Health 119, 235-239 (1999).
17. Provilus A, Abdallah M, McFarlane SI: Weight gain associated with antidiabetic medications. Therapy 8(2), 113-120 (2011).
18. Sonnett TE, Robinson JD, Bowen KA: Incretin-based therapies and their future in Type 2 diabetes mellitus. Therapy 8(2), 143-152 (2011).
19. Fonseca VA, Zinman B, Nauck MA, Goldfine AB, Plutzky J: Confronting the Type 2 diabetes epidemic: the emerging role of incretin-based therapies. Am. J. Med. 123, S2-S10 (2010).
20. Rodbard HW, Jellinger PS, Davidson JA et al.: Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on Type 2 diabetes mellitus: an algorithm for glycemic control. Endocr. Pract. 15, 540-559 (2009).
21. Buddineni JP, Chaudhary K, Whaley-Connell A: Biomarkers in diabetic kidney disease. Therapy 8(2), 121-127 (2011).